Birdwatch Archive

Birdwatch Note Rating

2023-04-08 14:13:49 UTC - HELPFUL

Rated by Participant: 6DD62212B01DF312B800E4630181D7FD90E29515B84D8D6EAC4F74D51B3B8ACF
Participant Details

Original Note:

The suspension of approval of the drug has to do with safety concerns, and the government has time to appeal the decision. "The Court does not second-guess FDA’s decision-making lightly," Kacsmaryk wrote. "But here, FDA acquiesced on its legitimate safety concerns” https://www.nbcnews.com/news/us-news/abortion-pill-case-texas-judge-halts-access-mifepristone-rcna72117

All Note Details

Original Tweet

All Information

  • noteId - 1644700160226648066
  • participantId -
  • raterParticipantId - 6DD62212B01DF312B800E4630181D7FD90E29515B84D8D6EAC4F74D51B3B8ACF
  • createdAtMillis - 1680963229875
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 1
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 16447001602266480666DD62212B01DF312B800E4630181D7FD90E29515B84D8D6EAC4F74D51B3B8ACF